Written by
Alan Stoddart
Mustafa Hassan, PhD
Dr Sanjay M Parekh
Share article:
Ultromics has been granted Breakthrough Device Status for its artificial intelligence platform for cardiac amyloidosis detection. It could herald a lucrative move for the vendor, but it could also have a wider impact.
Read the full insight with a Signify Premium Insights - Medical Imaging subscription
